These answers draw in part from “Exploring the Impact and Ethics of Private Equity” by Jay Katari, 💵💰🥩🚘🤣 (BehaviorLive), and extend it with peer-reviewed research from our library of 27,900+ ABA research articles. Clinical framing, BACB ethics code references, and cross-links below are synthesized by Behaviorist Book Club.
View the original presentation →Private equity refers to investment firms that acquire companies using a combination of investor capital and debt financing, with the goal of increasing the company's value and selling it for a profit within a defined timeframe (typically three to seven years). In ABA, this means PE firms purchase behavior analytic service providers and implement changes aimed at increasing profitability. These changes can include restructuring billing practices, adjusting caseload expectations, standardizing treatment protocols, and pursuing acquisitions of smaller practices. The impact on service delivery varies by organization but can include increased productivity demands on clinicians, changes to supervision structures, and financial incentives that may not always align with optimal client outcomes.
PE ownership is not always transparent, particularly after multiple acquisitions and rebrandings. Indicators include rapid growth through acquisitions, corporate leadership without clinical backgrounds, frequent changes in company name or branding, and venture capital language in company communications. During job interviews, ask directly about ownership structure, inquire about whether the organization has outside investors, and research the company through business databases. Ask about how clinical decisions are made, who has final authority over treatment plans, what productivity expectations look like, and how the organization handles situations where financial and clinical interests conflict. The answers to these questions will reveal much about the organization's priorities.
The BACB Ethics Code for Behavior Analysts (2022) does not specifically mention private equity, but multiple codes are directly applicable. Code 2.01 requires providing effective treatment regardless of organizational context. Code 3.01 establishes that the behavior analyst's primary obligation is to their client. Code 4.07 addresses conflicts of interest that may arise when financial incentives influence clinical decisions. Code 2.15 addresses appropriate discontinuation of services. These codes collectively establish that a behavior analyst's ethical obligations persist regardless of organizational ownership structure, and that client welfare must always take precedence over business considerations.
PE investment can bring legitimate benefits to ABA organizations, including access to capital for expansion into underserved areas, improved operational efficiency and infrastructure, investment in technology and data systems, and the ability to negotiate better reimbursement rates with insurance companies due to increased scale. Some PE-backed organizations have invested in clinical training programs, research initiatives, and professional development opportunities that smaller practices may not be able to afford independently. The key distinction is between PE firms that view clinical quality as a driver of long-term value and those that prioritize short-term financial extraction at the expense of clinical standards.
The impact on compensation and working conditions is variable. PE-backed organizations may offer higher starting salaries and signing bonuses to attract talent, which has influenced market-wide compensation. However, practitioners have reported that these financial incentives may come with productivity expectations that exceed sustainable levels, non-compete agreements that limit future employment options, and bonus structures tied to billable hours rather than clinical outcomes. Working conditions may include higher caseloads, less protected time for supervision and professional development, and reduced autonomy in clinical decision-making. Evaluating the total compensation package, including workload expectations and professional support, is more informative than comparing salary figures alone.
Begin by documenting specific instances where you believe financial considerations are negatively impacting clinical decisions. Present your concerns through appropriate organizational channels, framing them in terms of client outcomes and ethical obligations. If internal advocacy does not produce change, consult with colleagues, professional organizations, or ethics advisors. The BACB ethics hotline and state licensing boards can provide guidance. In some cases, reporting to insurance companies or regulatory bodies may be appropriate. Throughout this process, maintain thorough documentation of your clinical reasoning and any directives that conflict with it. Understanding your employment rights, including whistleblower protections, is also important.
Consolidation creates competitive pressures for smaller practices in several ways. PE-backed firms can offer higher salaries that make recruitment difficult for independents, negotiate more favorable insurance reimbursement rates due to their volume, invest more in marketing and referral development, and absorb short-term losses to build market share. Smaller practices may also face acquisition pressure from PE firms looking for add-on acquisitions. However, independent practices often retain advantages in clinical quality, staff retention, community relationships, and treatment individualization. Some independent practices have formed cooperative networks to achieve economies of scale while maintaining clinical autonomy.
This is one of the primary concerns raised by practitioners. Financial models that reward client retention and high service hours create structural incentives to maintain or increase service intensity even when clinical data might support reduction or discharge. This risk is particularly acute when BCBA compensation or performance evaluations are tied to caseload size or billable hours. It is important to note that this risk is not unique to PE-backed organizations and can exist in any fee-for-service model. However, PE's explicit focus on maximizing returns within a defined timeframe can intensify these pressures. Behavior analysts must maintain independent clinical judgment about service intensity and duration regardless of organizational context.
Insurance companies serve as a potential check on inappropriate service utilization through authorization processes, utilization review, and outcomes monitoring. However, the effectiveness of this oversight varies considerably by payer. Some insurance companies have implemented more rigorous utilization management in response to concerns about overutilization, which has sometimes resulted in blanket reductions that affect appropriate services as well. The relationship between PE-backed providers and insurance companies is complex, as large providers have significant negotiating power. Ideally, payers would focus on outcomes-based metrics rather than simple utilization caps, but the measurement infrastructure for this approach is still developing.
The profession can take several constructive steps. Professional organizations can develop position statements and practice guidelines that address organizational conflicts of interest. Research examining the relationship between ownership structures and clinical outcomes should be prioritized and funded. Transparency requirements, such as disclosing ownership structures to clients and payers, can be advocated for through regulatory channels. Accreditation standards can be strengthened to include governance and clinical independence criteria. Training programs can incorporate content on organizational ethics and business literacy. These approaches address systemic risks while acknowledging that not all PE involvement produces negative outcomes and that the field benefits from adequate investment and operational competence.
The ABA Clubhouse has 60+ on-demand CEUs including ethics, supervision, and clinical topics like this one. Plus a new live CEU every Wednesday.
Ready to go deeper? This course covers this topic with structured learning objectives and CEU credit.
Exploring the Impact and Ethics of Private Equity — Jay Katari · 1.5 BACB Ethics CEUs · $30
Take This Course →We extended these answers with research from our library — dig into the peer-reviewed studies behind the topic, in plain-English summaries written for BCBAs.
279 research articles with practitioner takeaways
256 research articles with practitioner takeaways
239 research articles with practitioner takeaways
1.5 BACB Ethics CEUs · $30 · BehaviorLive
Research-backed educational guide with practice recommendations
Side-by-side comparison with clinical decision framework
You earn CEUs from a dozen different places. Upload any certificate — from here, your employer, conferences, wherever — and always know exactly where you stand. Learning, Ethics, Supervision, all handled.
No credit card required. Cancel anytime.
All behavior-analytic intervention is individualized. The information on this page is for educational purposes and does not constitute clinical advice. Treatment decisions should be informed by the best available published research, individualized assessment, and obtained with the informed consent of the client or their legal guardian. Behavior analysts are responsible for practicing within the boundaries of their competence and adhering to the BACB Ethics Code for Behavior Analysts.